oral tirzepatide tablets MangoRx to Introduce Semaglutide and in Response to Increasing Patient Demand for GLP-1 Medications hormone GLP One medication, more than one

While Semaglutide has been instrumental in my weight loss journey, it is important to note that it is not a magic pill

10.3389/fonc.2017.00319 4

Semaglutide May Be Best For: Individuals who want a well-studied, FDA-approved medication with extensive long-term safety data Patients who prioritize cardiovascular risk reduction (supported by the SELECT trial) People seeking a medication with established insurance coverage pathways Individuals with moderate weight loss goals (10-15% of body weight) Patients who value the reassurance of a medication used by millions of people worldwide Retatrutide May Be Best For (Once Available): Individuals who need greater than 15-20% body weight loss Patients who have plateaued on semaglutide or tirzepatide People with significant metabolic dysfunction who may benefit from the glucagon receptors effects on liver fat and energy expenditure Individuals with MASH (metabolic dysfunction-associated steatohepatitis) given the glucagon receptors role in hepatic fat metabolism Patients willing to use a newer medication with less long-term safety data in exchange for potentially greater efficacy What to Expect During Treatment Starting Semaglutide Weeks 1-4: Starting dose of 0.25 mg weekly

Switch to a different molecule entirely tirzepatide (Zepbound), which produced 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks in the SURMOUNT-5 trial

If using a 5/8-inch needle on the thigh, always inject at 45 degrees unless you have substantial subcutaneous fat

Leg cramps were not formally classified as a dose-related event in pivotal trials, meaning they occurred at similar rates regardless of dose strength